Sierra Leone

Reimbursed Care Access

Sierra Leone maintains a highly prohibitive drug-control regime under the National Drugs Control Act (2008) and the Pharmacy and Drugs Act (2001); most classical psychedelic compounds (psilocybin, MDMA, DMT, mescaline, etc.) are effectively prohibited for non-research use and have no reimbursed medical pathway. Ketamine is available and in routine use as an anesthetic in Sierra Leonean hospitals, consistent with its listing on the WHO Model List of Essential Medicines, but psychedelic-assisted psychiatric medications (e.g., esketamine nasal spray) are not registered or reimbursed in routine care.